Literature DB >> 23657677

Effects of steroid administration and transcorneal electrical stimulation on the anatomic and electrophysiologic deterioration of nonarteritic ischemic optic neuropathy in a rodent model.

Takako Osako1, Hideki Chuman, Tomoyuki Maekubo, Michitaka Ishiai, Naoko Kawano, Nobuhisa Nao-I.   

Abstract

PURPOSE: To elucidate the effectiveness of steroid administration and transcorneal electrical stimulation (TES) on anatomic changes and visual function in a rodent model of nonarteritic ischemic optic neuropathy (rNAION).
METHODS: Methylprednisolone (20 mg/kg) was injected through a central venous catheter twice a day for 3 days. TES was delivered with biphasic square pulses of 1 ms/phase, 100 μA of current, and 20 Hz of frequency for 60 min 3 h after induction on the 1st, 4th, 7th, 14th, and 28th days.
RESULTS: Intravenous infusion of methylprednisolone significantly decreased the degree of acute disc edema but did not preserve the inner retinal thinning, decreasing the amplitude of scotopic threshold responses (STR) and decreasing retinal ganglion cell (RGC) numbers in rNAION. TES preserved the decreasing STR amplitude and the decreasing RGC numbers in rNAION.
CONCLUSION: Steroids are effective for reducing disc edema in the acute stage in rNAION. TES is effective for preserving decreasing RGC numbers and function in the chronic stage of rNAION.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23657677     DOI: 10.1007/s10384-012-0203-y

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  18 in total

1.  Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.

Authors:  Jeffrey L Bennett; Scott Thomas; Jeffrey L Olson; Naresh Mandava
Journal:  J Neuroophthalmol       Date:  2007-09       Impact factor: 3.042

2.  Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy.

Authors:  R C Sergott; M S Cohen; T M Bosley; P J Savino
Journal:  Arch Ophthalmol       Date:  1989-12

3.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

4.  Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT.

Authors:  Li Guo; Eduardo M Normando; Shereen Nizari; David Lara; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

5.  Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy.

Authors:  Takashi Fujikado; Takeshi Morimoto; Kenji Matsushita; Hiroshi Shimojo; Yoshitaka Okawa; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

6.  Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy.

Authors:  A C Arnold; R S Hepler; M Lieber; J M Alexander
Journal:  Am J Ophthalmol       Date:  1996-10       Impact factor: 5.258

7.  Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system.

Authors:  Takeshi Morimoto; Tomomitsu Miyoshi; Satoshi Matsuda; Yasuo Tano; Takashi Fujikado; Yutaka Fukuda
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-06       Impact factor: 4.799

8.  Vasodilatory effects of antivascular endothelium growth factor (VEGF) antibody, corticosteroid, and nitric oxide on the posterior ciliary arteries.

Authors:  Hideki Chuman; Naoko Kawano; Maki Kozawa; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2012-09-08       Impact factor: 2.447

9.  Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy.

Authors:  Steven L Bernstein; Yan Guo; Shalom E Kelman; Robert W Flower; Mary A Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

10.  Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-11       Impact factor: 3.117

View more
  7 in total

1.  Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy.

Authors:  Corina Radoi; Tony Garcia; Catherine Brugniart; Alain Ducasse; Carl Arndt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-01       Impact factor: 3.117

Review 2.  Electrical Stimulation as a Means for Improving Vision.

Authors:  Amer Sehic; Shuai Guo; Kin-Sang Cho; Rima M Corraya; Dong F Chen; Tor P Utheim
Journal:  Am J Pathol       Date:  2016-11       Impact factor: 4.307

Review 3.  The role of electrical stimulation therapy in ophthalmic diseases.

Authors:  Lin Fu; Amy Cheuk Yin Lo; Jimmy Shiu Ming Lai; Kendrick Co Shih
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-14       Impact factor: 3.117

4.  [Transcorneal electrical stimulation in primary open angle glaucoma].

Authors:  T Röck; L Naycheva; G Willmann; B Wilhelm; T Peters; E Zrenner; K U Bartz-Schmidt; F Gekeler; A Schatz
Journal:  Ophthalmologe       Date:  2017-10       Impact factor: 1.059

Review 5.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

Review 6.  Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats.

Authors:  Marie Claes; Lies De Groef; Lieve Moons
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

7.  Direct modulation of microglial function by electrical field.

Authors:  Anton Lennikov; Menglu Yang; Karen Chang; Li Pan; Madhu Sudhana Saddala; Cherin Lee; Ajay Ashok; Kin-Sang Cho; Tor Paaske Utheim; Dong Feng Chen
Journal:  Front Cell Dev Biol       Date:  2022-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.